Robert Chess, a director at Twist Bioscience Corp (NASDAQ:), a biotechnology company with a capitalization of $2.82 billion, recently sold shares of the company, according to a regulatory filing. According to InvestingPro data, TWST has shown strong momentum with a 30.67% year-to-date gain, although the stock remains highly volatile. On December 5, Chess had sold a total of 3,504 shares, generating approximately $181,696. Shares were traded at prices ranging from $51.7025 to $52.4511 per share. This transaction was made under an established trading plan.
In addition to sales, Chess exercised stock options, acquiring 3,504 shares at a price of $8.82 each, for a total of $30,905. Following this transaction, Chess owns 21,641 shares directly and an additional 42,528 shares indirectly through the Chess 1997 Trust.
In other recent news, Twist Bioscience has been active in the financial space. The company's 2024 fiscal year ended with a 27% increase in Q4 revenue to $84.7 million and annual revenue growth of 28%, reaching $330 million. The company also exceeded its quarterly margin guidance, gaining 45.1%, and saw its annual margin improve to 42.6%.
Analysts from Baird, TD Cowen, and Scotiabank (TSX:) have all been reiterating the positives at Twist Bioscience. Baird maintained an Outperform rating and raised the price target to $48. Scotiabank raised its target price on the company to $54, maintaining a Sector Outperform rating. TD Cowen reaffirmed a Buy rating on Twist Bioscience, highlighting the company's strong financial guidance through fiscal year 2025.
Twist Bioscience's preliminary guidance for FY25 expects revenue growth of between 17% to 20% year-on-year, driven primarily by Next (LON:) next generation sequencing (NGS) and SynBio components of SynBio. The company is also expected to improve its adjusted EBITDA by about $30 million year over year. These latest developments indicate a promising future for Twist Bioscience.
This article is powered by AI and updated by an editor. For more information see our T&C.